Pro-carboxypeptidase B humain, >=2,0 unités/mg de protéines

Code: p0059-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

TAFI is supplied in its 60 kDa zymogen form. The N-terminal of TAFI contains four N-linked glycans and a plasminogen recognition sequence. Hydrolysis ...


en savoir plus

Votre prix
£630.00 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

TAFI is supplied in its 60 kDa zymogen form. The N-terminal of TAFI contains four N-linked glycans and a plasminogen recognition sequence. Hydrolysis of the activation peptide by thrombin releases a 36-kDa active proteolytic domain homologous to tissue carboxypeptidase B. Complexation with thrombomodulin increases thrombin activation of TAFI 1250 fold. TAFI exerts it’;s inhibition of fibrinolytic activity by binding to plasminogen and by cleaving C-terminal lysine residues of fibrin resulting in the reduction of plasmin and tPA binding sites on fibrin. Experiments in TAFI-deficient mice point to a regulatory role on complement C5a.

Physical form

Solution containing 20 mM Hepes and 150 mM Sodium chloride. pH 7.4

Unit Definition

One unit will hydrolyze 1 micromole of Hippuryl-L-Arginine per minute at pH 7.4 at 25 °C.

Gene Informationhuman ... CPB1(1360)
mol wt60 kDa
Quality Level200
shipped indry ice
specific activity≥2.0 units/mg protein
storage temp.−70°C
UniProt accession no.P15086
Ce produit répond aux critères suivants: